CellVec is a certified GMP gene therapy Contract Development and Manufacturing Organisation (CDMO) that is a specialist provider of custom viral vectors for pre-clinical and clinical applications. With the use of our lentivirus-based CellVec Vector Platform, we set ourselves apart through the ability to overcome current technological bottlenecks in the upscale production of viral vectors and develop novel gene transfer technologies for advanced therapies in order to facilitate the advancement of our client’s products from bench-to-bedside for clinical applications.